
Around 1,000 doctors urge MPs to vote against ‘unsafe' assisted dying Bill
The Terminally Ill Adults (End of Life) Bill will return to the House of Commons for debate on Friday, with MPs expected to consider further amendments.
But in a letter, published this week, doctors from across the NHS have urged lawmakers to listen to those 'who would have to deliver the consequences of this deeply flawed Bill'.
They warn the Bill 'poses a real threat to both patients and the medical workforce'.
In its current form the proposed legislation, which applies only to England and Wales, would mean terminally ill adults with only six months left to live could apply for assistance to end their lives, subject to the approval of two doctors and an expert panel.
Last month, MPs approved a change in the Bill to ensure no medics would be obliged to take part in assisted dying.
Doctors already had an opt-out but the new clause extends that to anyone, including pharmacists and social care workers.
Encouraging or assisting suicide is currently against the law in England and Wales, with a maximum jail sentence of 14 years.
The letter to MPs said: 'As experienced medical professionals who regularly work with dying patients and who have reviewed the worldwide evidence on assisted dying, it is our opinion that this Bill poses a real threat to both patients and the medical workforce, and we urge you to vote against it.
'We are concerned that the private member's Bill process has not facilitated a balanced approach to the collection of evidence and input from key stakeholders including doctors, people with disabilities and other marginalised groups.
'This Bill will widen inequalities, it provides inadequate safeguards and, in our collective view, is simply not safe.
'This is the most important piece of healthcare legislation for 60 years and we urge you to listen to the doctors who would have to deliver the consequences of this deeply flawed Bill.'
Sir Ed Davey welcomed the letter on Monday, telling Sky News he had 'real concerns'.
'I have voted against this assisted dying legislation, as I did on previous occasions,' the Liberal Democrat leader said.
'I have real concerns about the pressure on individuals, that they will put on themselves, if they think they are a burden on their family, so I welcome this letter.'
He added: 'I hope, as time has gone on, as the arguments have been better exposed, that MPs will switch sides and join the side that I and many MPs are on.'
But Sir Chris Bryant said he would be voting in favour.
The technology minister told Sky News: 'The Government doesn't have a formal position at all and individual members are free to choose how they vote.
'I'm not going to hide my own personal preference. I abstained on the first time round, I decided I wasn't going to vote because I wanted to hear the debate.
'I have listened to a lot of the debate. Of course, I don't want anybody to feel that they are a burden on society and that should lead them towards taking their own life, but I also have heard the cries of people who are absolutely miserable, and that's why I will be voting for the Bill.'
Some of the Bill's opponents have urged MPs to focus on improving end-of-life care rather than legislating for assisted dying.
Ahead of last month's Commons debate on the Bill, two royal medical colleges raised concerns over the proposed legislation.
The Royal College of Physicians (RCP) said it believes there are 'concerning deficiencies', while the Royal College of Psychiatrists (RCPsych) said it has 'serious concerns' and cannot support the Bill.
People with terminal illnesses, surrounded by loved ones, display their dying wishes on tags outside the Palace of Westminster in London to urge MPs to support the Terminally Ill Adults (End of Life) Bill (Jas Lehal/PA)
Opinions among members of the medical profession remain varied, with TV doctor Hilary Jones describing assisted dying for the terminally ill as 'kind and compassionate', adding that he would help a patient to end their life if the law was changed.
The GP, often seen on ITV's Good Morning Britain and the Lorraine show, told the PA news agency he believes medicine will go 'back to the Dark Ages' if proposed legislation being considered at Westminster is voted down.
While Friday is expected to see debate on further amendments to the Bill, it is thought a vote on the overall legislation might not take place until the following Friday, June 20.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Leader Live
22 minutes ago
- Leader Live
Kendall to add protections to welfare Bill amid backlash to cuts
The package of measures is aimed at reducing the number of working-age people on sickness benefits, and the Government hopes they can save £5 billion a year by the end of the decade. The proposals include tightening of the eligibility criteria for personal independence payment (Pip), the main disability benefit in England, and cutting the sickness-related element of universal credit (UC). Dozens of Labour MPs last month urged the Prime Minister to pause and reassess planned cuts, saying the proposals are 'impossible to support'. Work and Pensions Secretary Liz Kendall told the Guardian there will be extra protections added to the Bill when it is published next week. She said: 'When we set out our reforms we promised to protect those most in need, particularly those who can never work. 'I know from my 15 years as a constituency MP how important this is. It is something I take seriously and will never compromise on. 'That is why we are putting additional protections on the face of the Bill to support the most vulnerable and help people affected by the changes. 'These protections will be written into law, a clear sign they are non-negotiable.' A Government impact assessment published alongside the reforms warned some 250,000 people, including 50,000 children, across England, Scotland and Wales, could fall into relative poverty after housing costs as a result of the changes.


Glasgow Times
36 minutes ago
- Glasgow Times
Kendall to add protections to welfare Bill amid backlash to cuts
The package of measures is aimed at reducing the number of working-age people on sickness benefits, and the Government hopes they can save £5 billion a year by the end of the decade. The proposals include tightening of the eligibility criteria for personal independence payment (Pip), the main disability benefit in England, and cutting the sickness-related element of universal credit (UC). Dozens of Labour MPs last month urged the Prime Minister to pause and reassess planned cuts, saying the proposals are 'impossible to support'. Work and Pensions Secretary Liz Kendall told the Guardian there will be extra protections added to the Bill when it is published next week. She said: 'When we set out our reforms we promised to protect those most in need, particularly those who can never work. 'I know from my 15 years as a constituency MP how important this is. It is something I take seriously and will never compromise on. 'That is why we are putting additional protections on the face of the Bill to support the most vulnerable and help people affected by the changes. 'These protections will be written into law, a clear sign they are non-negotiable.' A Government impact assessment published alongside the reforms warned some 250,000 people, including 50,000 children, across England, Scotland and Wales, could fall into relative poverty after housing costs as a result of the changes.


North Wales Chronicle
4 hours ago
- North Wales Chronicle
Weight loss jabs could be transformative, says outgoing NHS England official
Cholesterol-busting statins are one of the most commonly prescribed drugs in the UK, with around seven to eight million people taking them to cut their chance of heart attack and stroke. An estimated 1.5 million are taking weight loss jabs in the UK. Professor Sir Stephen Powis, the outgoing medical director of NHS England, said the NHS needs to go 'further and faster' to 'turn the tide' on rising levels of obesity. Later this month GPs in England will be allowed to prescribe mounjaro, also known as tirzepatide, for the first time. Patients previously needed to access the drugs through a special weight loss service. Speaking at the NHS ConfedExpo conference in Manchester, Sir Stephen hailed the rollout in GP surgeries as an 'exciting milestone' and said NHS officials are also examining ways to 'broaden access to the drugs'. Around 29% of adults in the UK are obese. Sir Stephen said: 'Right now, obesity is estimated to cost the NHS approximately £11.4 billion every year – this financial burden is unsustainable for the NHS and wider economy. 'We have to turn the tide. We have to and will go further, and faster. 'In just a few years from now, some of today's weight loss drugs will be available at much lower cost. This could completely transform access to these innovative treatments. 'But we will and must be guided by the evidence base and must do this safely and sustainably, in a way that ensures that we are equipped as a health service to deal with the demand.' He said he is not 'starry-eyed' about weight loss drugs, adding they are 'no silver bullet'. He told reporters: 'These medicines can be harmful if they are prescribed without the right checks and wraparound care – they can have side effects, including nausea, dehydration and inflammation of the pancreas, and a worrying number of people are continuing to access them without appropriate checks via the internet. 'We are ambitious and determined to explore different methods of delivery and strengthen the evidence base and will do so alongside this phased rollout, but this is a historic first step in widening access, with 220,000 people set to benefit from the rollout over the first three years. 'So I think over time it's highly likely that they will become more widespread, the evidence base will increase, we will learn better how to deploy them, we'll learn how long people need to be on them, and in terms of weight reduction, how much weight reduction is maintained once people come off – that's a big unknown. 'We see this every time we have a new class of drugs in the early days. But there's still much more to learn. 'There will be more drugs coming on the market; there will be different prices for drugs, we will get to generics, which means that prices will fall. 'We have been through this with statins, and the use of statins is now very different from when they first came out, and I've no doubt that will be the same for these drugs. 'So it's very exciting, but we're in the foothills of learning how to use them.' Asked about statins, Sir Stephen said: 'So firstly, obesity is associated with a whole set of conditions (such as) kidney disease, cardiovascular disease, respiratory conditions. 'So in reducing weight, you will, by the very nature of doing that, be reducing the risk of a whole set of difficult conditions and aiding with their management where people already have them. 'Whether the drugs have effects beyond that, I think, is a research question, and there will be an evidence base being generated. 'And it's not completely unusual for drugs over time to be found to have effects that go over and beyond what they were initially designed for. 'So I think we will wait and see. But obviously, the first task, amongst all the excitement and all the discussion and debate, is to actually get on and deploy tirzepatide in particular. 'We have been focused on getting this rolled out by the end of this month… and that is going to be a really exciting milestone. 'It's going to be a very exciting journey, and there will be things on the way that we haven't expected.' He added: 'We set out the our plan for uptake – Nice (National Institute for Health and Care Excellence) have asked for a review of that after three years, which is quite right, because it's quite a long horizon. 'Cost is one element of that, but I think we will learn more about the outcomes that these drugs are driving in terms of lower cardiovascular events and reducing the conditions that we know associated with obesity. 'So absolutely, cost is one element of that, but it's not the only element. We want to look carefully at what the science tells us.' Sir Stephen added: 'When I look back when dialysis came in, we didn't use dialysis for older people. Over years the technology improved, we got more confident, more people were able to access the treatment. 'So we've much to learn with these drugs. It's a really exciting time.' He went on: 'We want to broaden the ways in which you can access these drugs – so we're very interested in thinking about pharmacies, thinking about digital. 'We will deliver the structured support through a combination of digital and face-to-face. 'But we want to innovate. This can be a model that is not just about GP prescribing, but we need to learn how to do that.'